Affinity Biosensors, LLC
Multi-Drug Resistant Organism Questionnaire

Home / MDRO Survey

Please enable JavaScript in your browser to complete this form.

Name

First

Last

Which of these antibiotics would you like to see on a new MDRO panel targeting blood stream infections?

Low priority being 0, High priority being 10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Low High
0	1	2	3	4	5	6	7	8	9	10

Are there any newer antibiotics that you believe should be included due to emerging resistance patterns?

What best describes your use of Acinetobacter-specific antibiotic Sulbactam-Durlobactam in treating blood-stream infections?

Do not plan to treat with Sulbactam-Durlobactam
Prefer Sulbactam-Durlobactam treatment upon positive identification of Acinetobacter baumannii
Prefer Sulbactam-Durlobactam treatment upon positive identification of Acinetobacter baumannii and susceptible AST result
Prefer more cost-effective treatments over Sulbactam-Durlobactam upon positive identification of Acinetobacter baumannii and/or susceptible AST results